DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Harbeck N, Würstlein R.
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: Evidence and clinical considerations.
Drugs 2013;
73: 1665-1680
We do not assume any responsibility for the contents of the web pages of other providers.